资金管理

Search documents
南京公用: 募集资金使用管理制度
Zheng Quan Zhi Xing· 2025-05-27 09:25
南京公用发展股份有限公司 (尚需经公司股东大会审议通过) 二○二五年五月 南京公用发展股份有限公司 第一章 总则 第一条 为规范公司募集资金的管理和使用,最大限度地保障投资者的利益, 依据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易所股 票上市规则》《首次公开发行股票注册管理办法》《上市公司证券发行注册管理 办法》《上市公司信息披露管理办法》等法律、法规及《公司章程》的有关规定, 结合公司的实际情况,制定本制度。 第三条 公司募集资金应当专款专用。公司使用募集资金应当符合国家产业 政策和相关法律法规,践行可持续发展理念,履行社会责任,原则上应当用于主 营业务,有利于增强公司竞争能力和创新能力。募集资金不得用于持有财务性投 资,不得直接或者间接投资于以买卖有价证券为主要业务的公司。 第四条 公司应当建立并完善募集资金存放、管理、使用、改变用途、监督 和责任追究的内部控制制度,明确募集资金使用的分级审批权限、决策程序、风 险控制措施及信息披露要求,规范使用募集资金。 公司董事会应当持续关注募集资金存放、管理和使用情况,有效防范投资风 险,提高募集资金使用效益。 第五条 公司的控股股东、实际控制人 ...
国光电器: 第十一届董事会第十九次会议决议公告
Zheng Quan Zhi Xing· 2025-05-27 09:09
Group 1 - The company held the 19th meeting of the 11th Board of Directors on May 27, 2025, with all 5 directors present, achieving a 100% attendance rate [1] - The meeting discussed and approved adjustments to the company's organizational structure to enhance management efficiency and governance [1] - The company plans to open two special accounts for raised funds in its subsidiary, Guoguang Acoustics (Vietnam) Co., Ltd., and authorized management to sign supplementary agreements for fund supervision [2]
林州重机集团股份有限公司关于全资子公司 为公司融资业务提供担保的进展公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-05-26 22:42
Fundraising Overview - The company raised a total of RMB 1,112,999,994.00 through a non-public offering of 82,444,444 shares at a price of RMB 13.50 per share, with a net amount of RMB 1,089,457,834.00 after deducting issuance costs [1][2] - The funds were deposited in a special account at China Construction Bank, with a tripartite supervision agreement signed with Huatai United Securities [2] Fund Usage and Account Closure - The special account for fundraising has been fully utilized, with a remaining balance of RMB 2,589.4 transferred to the company's own funds, leading to the account's closure [3] - The company has completed the account cancellation procedures, terminating the tripartite supervision agreement with the bank and the securities firm [3] Guarantee Situation - The company signed a loan agreement with Zhongyuan Bank for RMB 37.4 million, with its wholly-owned subsidiary providing a joint liability guarantee [8] - The total guarantee amount provided by the company and its subsidiaries exceeds 100% of the latest audited net assets, with specific figures indicating a total guarantee balance of RMB 108,963.38 million, which is 170.98% of the latest audited net assets [8][13] Company Information - The company, Linzhou Heavy Machinery Group Co., Ltd., was established on May 8, 2002, with a registered capital of RMB 816,370,000 [9] - The company operates in the manufacturing and sales of coal mining machinery, explosion-proof electrical appliances, and other related services [9]
浙江华海药业股份有限公司 关于签订募集资金三方监管协议的 公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-05-26 22:40
根据中国证券监督管理委员会《关于同意浙江华海药业股份有限公司向特定对象发行股票注册的批复》 (证监许可〔2024〕480号),浙江华海药业股份有限公司(以下简称"公司")向特定对象发行人民币 普通股(A股)数量为41,152,263股,发行价格为14.58元/股,募集资金总额为599,999,994.54元,扣除发 行费用17,680,629.03元(不含增值税)后,募集资金净额为582,319,365.51元。上述募集资金已于2025年 3月14日全部到位。天健会计师事务所(特殊普通合伙)对上述募集资金到位情况进行了审验,并出具 了《验资报告》(天健验〔2025〕48号)。 二、募集资金三方监管协议的签订情况 为提高募集资金的使用效率,减少财务费用,降低公司运营成本,维护投资者的利益,在确保募集资金 项目建设的资金需求以及募集资金使用计划正常进行的前提下,公司计划使用部分闲置募集资金暂时补 充流动资金(仅限于与公司主营业务相关的生产经营使用),总额不超过人民币1.81亿元,使用期限不 超过12个月,自公司第八届董事会第三次会议审议通过之日(2025年4月28日)起计算。公司将严格按 照中国证监会、上海证券交 ...
浙江泰鸿万立科技股份有限公司关于子公司开立募集资金专项账户并签订募集资金专户存储四方监管协议的公告
Shang Hai Zheng Quan Bao· 2025-05-26 19:01
证券代码:603210 证券简称:泰鸿万立 公告编号:2025-011 浙江泰鸿万立科技股份有限公司关于子公司开立募集资金专项账户 并签订募集资金专户存储四方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金的基本情况 经中国证券监督管理委员会《关于同意浙江泰鸿万立科技股份有限公司首次公开发行股票注册的批复》 (证监许可〔2024〕1660号)同意注册,并经上海证券交易所同意,公司首次公开发行人民币普通股 (A股)8,510.00万股,发行价格为8.60元/股,本次发行募集资金总额为73,186.00万元,扣除发行费用 10,307.69万元(不含增值税)后,募集资金净额为62,878.31万元。上述募集资金已于2025年4月3日全部 到位。容诚会计师事务所(特殊普通合伙)对本次募集资金到位情况进行了审验,并出具了《验资报 告》(容诚验字[2025]230Z0027号)。公司已对上述募集资金进行专户存储管理,并与保荐机构、募集 资金专户开户银行签署《募集资金专户存储三方监管协议》。 二、本次《募集资金 ...
三生国健: 三生国健:关于将部分项目节余资金用于暂时补充流动资金以及调整部分募投项目拟投入募集资金金额的公告
Zheng Quan Zhi Xing· 2025-05-26 11:17
证券代码:688336 证券简称:三生国健 公告编号:2025-025 三生国健药业(上海)股份有限公司 关于将部分项目节余资金用于暂时补充流动资金以 及调整部分募投项目拟投入募集资金金额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ●三生国健药业(上海)股份有限公司(以下简称"公司"或"三 生国健")拟将"抗体药物生产新建项目"、"抗肿瘤抗体药物的新 药研发项目"、"研发中心建设项目"及"补充营运资金项目"节余 资金 6,662.82 万元暂时补充流动资金。 ●拟缩减"创新抗体药物产业化及数字化工厂建设项目"募集 资金承诺投资总额,由 40,000.00 万元调减为 32,000.00 万元,调减 金额为 8,000.00 万元;拟增加"自身免疫及眼科疾病抗体药物的新 药研发项目"募集资金承诺投资总额,由 61,000.00 万元调增为 ●公司于 2025 年 5 月 26 日召开第五届董事会第八次会议和第五 届监事会第五次会议,审议通过了《关于将部分项目节余资金用于暂 时补充流动资金以及调整部 ...
立达信: 国金证券关于立达信物联科技股份有限公司将部分募投项目节余募集资金用于其他募投项目及部分募投项目延期的核查意见
Zheng Quan Zhi Xing· 2025-05-26 10:13
国金证券股份有限公司(以下简称"保荐机构")为立达信物联科技股份有 限公司(以下简称"立达信"或"公司")首次公开发行股票并上市的保荐机构, 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司章程指引》 《证券发行上市保荐业务管理办法》《上市公司监管指引第2号——上市公司募 集资金管理和使用的监管要求》《上海证券交易所股票上市规则》《上海证券交 易所上市公司自律监管指引第1号——规范运作》等有关规定,对立达信将部分 募投项目节余募集资金用于其他募投项目及部分募投项目延期的事项进行了核 查,核查情况如下: 一、募集资金基本情况 (一)实际募集资金金额及到位时间 经中国证券监督管理委员会《关于核准立达信物联科技股份有限公司首次公 开发行股票的批复》 (证监许可〔2021〕2186 号)核准,公司向社会公开发行人 民币普通股(A 股)5,000 万股,每股面值为人民币 1.00 元,发行价格为人民币 万元(不含增值税)后,实际募集资金净额为人民币 77,135.33 万元。 国金证券股份有限公司关于立达信物联科技股份有限公司 将部分募投项目节余募集资金用于其他募投项目及部分募投项 目延期的核查意见 前述 ...
天洋新材: 中信证券股份有限公司关于天洋新材(上海)科技股份有限公司部分募投项目终止及部分募投项目延期的核查意见
Zheng Quan Zhi Xing· 2025-05-26 09:20
Core Viewpoint - Tianyang New Materials (Shanghai) Technology Co., Ltd. has decided to terminate certain fundraising projects and postpone others due to changes in the real estate industry and overall market demand, aiming to maximize the efficiency of fund usage and protect investor interests [1][5][11]. Fundraising Overview - In 2020, the company raised approximately RMB 386.99 million through a private placement of 16,929,124 shares at RMB 22.86 per share [1]. - In 2022, the company raised approximately RMB 986.50 million by issuing 99,847,765 shares at RMB 9.88 per share, with a net amount of RMB 967.39 million after deducting issuance costs [2][3]. Fund Investment Projects - The 2020 fundraising was allocated to projects including high-end environmentally friendly wall fabrics, with a total investment of RMB 148 million, of which RMB 37.39 million was utilized by May 2025 [3][4]. - The 2022 fundraising was directed towards photovoltaic film projects, with a total investment of RMB 154.54 million, and RMB 96.74 million utilized by May 2025 [4]. Termination of Fundraising Projects - The "High-end Environmentally Friendly Wall Fabric Project" has reached 100% investment progress, with a total of RMB 18.55 million expected to be used. The project will be terminated due to insufficient market demand in the home decoration sector [5][6]. - The remaining funds from the terminated project will be permanently redirected to supplement working capital for daily operations [4][5]. Postponement of Fundraising Projects - The company plans to postpone the completion of the "Hot Melt Adhesive Materials Project" and the "Photovoltaic Film Projects" to June 2026 due to delays in construction progress and market conditions [8][9]. - Factors affecting the delay include increased competition in the hot melt adhesive market and low demand for photovoltaic components, which have impacted project timelines [9][10]. Impact of Project Changes - The termination of the "High-end Environmentally Friendly Wall Fabric Project" is not expected to adversely affect the company's normal operations, as existing production lines can meet current needs [6][10]. - The postponement of projects is a cautious decision based on objective reasons and does not alter the intended use of funds or harm shareholder interests [10][11]. Approval Process - The decisions regarding the termination and postponement of projects were approved in the board and supervisory meetings held on May 26, 2025, and will be submitted for shareholder approval [11][12].
熊猫乳品: 关于开立募集资金专户并签订募集资金四方监管协议的公告
Zheng Quan Zhi Xing· 2025-05-26 08:16
Fundraising Overview - Panda Dairy Group Co., Ltd. has received approval from the China Securities Regulatory Commission for its initial public offering and has successfully raised funds [1][2] - The company has established a dedicated account for the raised funds and signed a tripartite supervision agreement with the bank and the sponsor [2][3] Fund Allocation - The company has decided to allocate 18 million yuan of the raised funds for a new project, specifically the "Ding'an Annual Production of 5,000 Tons of Food Raw Materials Project," with 10 million yuan earmarked for related tax fees and 8 million yuan for capital increase in Nanhang Pharmaceutical [2][3] - The name of Nanhang Pharmaceutical has been changed to Hainan Yeda Food Technology Co., Ltd. to align with development needs [2] Project Implementation - The company has approved Hainan Yeda as the implementing entity for the food raw materials project and has opened a dedicated fundraising account for this purpose [3][4] - The dedicated account is managed by China Construction Bank and is specifically for storing and using the funds related to the new project [3][4] Regulatory Compliance - The fundraising management is in accordance with relevant regulations and guidelines to protect the rights of minority investors [4][5] - The agreement stipulates that the funds must not be used for non-project purposes and outlines the responsibilities of all parties involved in the management and supervision of the funds [4][5][6] Monitoring and Reporting - The sponsor has the right to conduct on-site investigations and inquiries regarding the use of the funds, ensuring compliance with the established guidelines [5][6] - Any significant transactions or changes in the account must be reported to the sponsor within specified timeframes [6][7]
星源卓镁: 前次募集资金使用情况鉴证报告
Zheng Quan Zhi Xing· 2025-05-26 08:15
Core Points - The report provides an independent assurance conclusion on the use of previously raised funds by Ningbo Xingyuan Zhuomei Technology Co., Ltd. as of March 31, 2025, confirming compliance with regulatory guidelines [1][2][5] - The total amount raised from the initial public offering (IPO) was RMB 688 million, with a net amount of RMB 596.32 million after deducting related issuance costs, which was received in December 2022 [3][4] - The company has established a dedicated account for the raised funds and has implemented a management system to ensure the funds are used in a regulated, safe, efficient, and transparent manner [3][4] Fund Management - As of March 31, 2025, the balance of the raised funds was RMB 106.44 million, which includes RMB 39 million in cash management products and RMB 67.44 million in the dedicated account [4][7] - The company has utilized RMB 21.55 million of the raised funds in 2022 and has generated RMB 8.4 million in financial returns from the management of these funds [4][5] - The company has not made any changes to the actual investment projects funded by the raised capital as of the reporting date [4][5] Investment Projects - The company has committed to investing in projects such as high-strength magnesium alloy precision casting and has not reported any discrepancies between the actual investment amounts and the promised amounts [4][5] - The total actual investment in the projects funded by the raised capital was RMB 49.92 million, with no significant differences reported [4][5] - The company has also approved the use of excess raised funds for new projects, ensuring that the investment plans remain unaffected [5][6]